🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07537504
Starting soon Observational

Language Function Reorganization in Patients With Arteriovenous Malformations

NCT07537504 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Tiantan Hospital
Phase
Observational
Started
2026-04-20
Last updated
2026-04-17

Condition(s) studied

Brain Arteriovenous Malformations

Investigational drug(s) / intervention(s)

MRI

MRI: All participants underwent MRI scans

Study summary

Brain arteriovenous malformation (AVM) is generally considered as a congenital lesion. Its unique clinical manifestation is that when the unruptured AVM involves and destroys the language function area of the left hemisphere, the patient has almost no language disorder. This phenomenon is distinct from those of acquired diseases such as cerebral infarction and gliomas. There is a hypothesis that it might be associated with that the occurrence of AVM is earlier than period of language learning. Therefore, patients with AVMs involving language areas can be regarded as population whose language areas are congenital "knocked out" but the language functions remain normal, which provide a special model and new insights for language reorganization research. Previous studies have found that the right hemisphere plays an important role in the remodeling of language function in patients with AVMs, but the specific mechanism remains unclear. The purpose of this study is to further elaborate the role of the right cerebral hemisphere in the reorganized language network and the interhemispheric interaction mechanisms in patients with AVMs involving the language areas, using multimodal magnetic resonanceimaging and from multiple dimensions such as functional remodeling, white matter pathway remodeling, structural remodeling, etc., so as to further understand the remodeling mechanism of the Chinese language network after damage of language areas, and also to provide a theoretical basis for the protection of language function in brain network surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * AVM located within left-hemisphere language regions * right-handedness * native Mandarin Chinese speakers * age 18-60 years * high school education or above Exclusion Criteria: * comorbid neurological or psychiatric disorders * AVM-related intracranial hemorrhage within the past month * prior AVM treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
No. 119 South 4th Ring West Road, Fengtai District, Beijing 100070, China Beijing China

More Beijing Tiantan Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07537504 on ClinicalTrials.gov ↗ ← All trials in China